Mei Ding

Affiliated with

Research Area

Biography

Mei Ding has not added Biography.
If you are Mei Ding and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation. Frontiers in immunology\| PubMed ID: 39399498	2024
Blockade of PI3K/AKT pathway enhances sensitivity of Raji cells to chemotherapy through down-regulation of HSP70. Cancer cell international\| PubMed ID: 23706027	2013
[Paraneoplastic pemphigus as the first manifestation of non-Hodgkin's lymphoma: a case report and literatures review]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\| PubMed ID: 26462645	2015
Antagonism between Hedgehog and Wnt signaling pathways regulates tumorigenicity. Oncology letters\| PubMed ID: 29391876	2017
Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing. Molecular medicine reports\| PubMed ID: 30942411	2019
Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score. Cancer medicine\| PubMed ID: 36866830	2023
Dyslipidemia in the First 100 days and the Association with Acute Graft-versus-host Disease after Allogeneic Stem Cell Transplantation: A Single-center Retrospective Study in China. Transplant immunology\| PubMed ID: 36972854	2023
Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma. Frontiers in nutrition\| PubMed ID: 37252237	2023
The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Frontiers in oncology\| PubMed ID: 37333805	2023
Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis. Annals of medicine\| PubMed ID: 38010751	2023
Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study. Hematology (Amsterdam, Netherlands)\| PubMed ID: 38205814	2024
Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin. Frontiers in immunology\| PubMed ID: 38650933	2024
Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma. Molecular biotechnology\| PubMed ID: 39436635	2025
Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway. Frontiers in immunology\| PubMed ID: 40083556	2025
Recent advances in S-palmitoylation and its emerging roles in human diseases. Journal of hematology & oncology\| PubMed ID: 40890756	2025
Investigate the co-culture effects of BM-mesenchymal stem cells on the promotion of apoptotic pathways of CD34leukemic stem cells. BioImpacts : BI\| PubMed ID: 41064390	2025
Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma. Discover oncology\| PubMed ID: 41222800	2025